PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists reveal parchment's hidden stories

The new technique of analyzing DNA found in ancient parchments can shine a focused light on the development of agriculture across the centuries

Scientists reveal parchment's hidden stories
2014-12-08
(Press-News.org) Dublin, IRELAND Monday December 8th, 2014 - Millions of documents stored in archives could provide scientists with the key to tracing agricultural development across the centuries, according to new research completed at Trinity College Dublin and the University of York.

Amazingly, thanks to increasingly progressive genetic sequencing techniques, the all-important historical tales these documents tell are no longer confined to their texts; now, vital information also comes from the DNA of the parchment on which they are written.

Researchers used these state-of-the-art scientific techniques to extract ancient DNA and protein from tiny samples of parchment from documents from the late 17th and late 18th centuries. The resulting information enabled them to establish the type of animals from which the parchment was made, which, when compared to genomes of their modern equivalents, provides key information as to how agricultural expansion shaped the genetic diversity of these animals.

This information therefore gives the scientists an unrivalled resource to analyse the development of livestock husbandry across the centuries. The research has just been published in the international, peer-reviewed journal Philosophical Transactions of the Royal Society B.

Professor of Population Genetics at Trinity College Dublin, Daniel Bradley, said: "This pilot project suggests that parchments are an amazing resource for genetic studies that consider agricultural development over the centuries. There must be millions stored away in libraries, archives, solicitors' offices and even in our own attics. After all, parchment was the writing material of choice for thousands of years, going back to the Dead Sea Scrolls."

He added: "Wool was essentially the oil of times gone by, so knowing how human change affected the genetics of sheep through the ages can tell us a huge amount about how agricultural practices evolved."

To conduct their research, geneticists at Trinity extracted DNA from two tiny (2x2cm) samples of parchment provided by the University of York's Borthwick Institute for Archives. Meanwhile, researchers in the Centre for Excellence in Mass Spectrometry at York extracted collagen (protein) from the same parchment samples.

The first sample showed a strong affinity with northern Britain, specifically the region in which black-faced breeds such as Swaledale, Rough Fell and Scottish Blackface are common, whereas the second sample showed a closer affinity with the Midlands and southern Britain where the livestock Improvements of the later 18th century were most active.

If other parchments show similar levels of DNA content, resulting sequencing could provide insights into the breeding history of livestock - particularly sheep - before, during and after the agricultural improvements of the 18th century that led to the emergence of regional breeds of sheep in Britain.

Professor Matthew Collins, of the Department of Archaeology at York, who heads the University's BioArCh research centre, said: "We believe the two specimens derive from an unimproved northern hill-sheep typical in Yorkshire in the 17th century, and from a sheep derived from the 'improved' flocks, such as those bred in the Midlands by Robert Bakewell, which were spreading through England in the 18th century. We want to understand the history of agriculture in these islands over the last 1,000 years and, with this breath-taking resource, we can."

INFORMATION:

The research was funded by a grant from the European Research Council. The paper can be viewed here after embargo: http://rstb.royalsocietypublishing.org/content/370/1660.toc

Media Contact:

Daniel Bradley, Professor of Population Genetics, Trinity College Dublin, at dbradley@tcd.ie, or Tel: +353-87-207-9451

Thomas Deane, Press Officer for the Faculty of Engineering, Mathematics, and Science, Trinity College Dublin, at deaneth@tcd.ie, or Tel: +353-1-896-4685

Matthew Collins, Professor of Archaeology, University of York, at matthew.collins@york.ac.uk, or Tel: +44-7955-888101

David Garner, Head of Media Relations, University of York, at david.garner@york.ac.uk or Tel: +44-1904-322153

Additional Notes to Editor

Parchment a Huge Reservoir of DNA Information

Before the mass production of paper, parchment was the major medium for legal documents and until the widespread adoption of typewriters, they were a clerk's preferred medium for many formal legal documents and records.

Parchment has a number of properties that make it compelling material for DNA extraction and analysis. Parchments are made from the skins of domestic animals, particularly livestock, and their manufacture results in robust artefacts, which can survive intact for many centuries.

Secondly, they are abundant and because of their enduring legal value they have generally been carefully managed. In the 20th century, this has included protecting them from both high temperatures and fluctuating humidity.

Thirdly, unlike bone remains, of which only a small percentage have been excavated, parchments are above ground, archived and in the case of legal documents, directly related to specific dates - a level of resolution largely unachievable with any other historic DNA source. Even undated documents can be dated palaeographically to a resolution better and more cheaply than radiocarbon dating.

About Trinity College Dublin

Trinity College Dublin, founded in 1592 is Ireland's oldest university and today has a vibrant community of 17,000 students. It is recognised internationally as Ireland's premier university. Cutting-edge research, technology and innovation places the university at the forefront of higher education in Ireland and globally.

It encompasses all major academic disciplines, and is committed to world-class teaching and research across the range of disciplines in the arts, humanities, engineering, science, social and health sciences.

Trinity is Ireland's leading university across all international rankings, and was ranked 61st globally in 2013 QS World University Rankings

http://www.tcd.ie.

** Note there is video available here: http://youtu.be/f0e-rmri89M **

** Note there are also images and captions available here: http://www.york.ac.uk/news-and-events/features/2014/parchment-hidden-story


[Attachments] See images for this press release:
Scientists reveal parchment's hidden stories Scientists reveal parchment's hidden stories 2 Scientists reveal parchment's hidden stories 3

ELSE PRESS RELEASES FROM THIS DATE:

Correcting metabolic abnormalities may help lessen urinary problems

2014-12-08
Metabolic syndrome is linked with an increased frequency and severity of lower urinary tract symptoms, but weight loss surgery may lessen these symptoms. The findings, which come from two studies published in BJU International, indicate that urinary problems may be added to the list of issues that can improve with efforts that address altered metabolism. Lower urinary tract symptoms related to urinary frequency and urgency, bladder leakage, the need to urinate at night, and incomplete bladder emptying are associated with obesity in both men and women. To see if these ...

Dartmouth/Univ. of Exeter Study: Correcting myths about the flu vaccine

2014-12-08
HANOVER, N.H. - December 8, 2014 - With health systems in the U.S., U.K., and around the world trying to increase vaccination levels, it is critical to understand how to address vaccine hesitancy and counter myths about vaccine safety. A new article in the journal "Vaccine" concludes, however, that correcting myths about vaccines may not be the most effective approach to promoting immunization among vaccine skeptics. The study, which was co-authored by Brendan Nyhan, an assistant professor of government at Dartmouth College, and Jason Reifler, a senior lecturer of politics ...

Penn researchers announce latest results of investigational cellular therapy

2014-12-08
SAN FRANCISCO - The latest results of clinical trials of more than 125 patients testing an investigational personalized cellular therapy known as CTL019 will be presented by a University of Pennsylvania research team at the 56th American Society of Hematology Annual Meeting and Exposition. Highlights of the new trial results will include a response rate of more than 90 percent among pediatric acute lymphoblastic leukemia patients, and results from the first lymphoma trials testing the approach, including a 100 percent response rate among follicular lymphoma patients and ...

Narrow subset of cells is responsible for metastasis in multiple myeloma, study finds

2014-12-08
Although it is among the most highly metastatic of all cancers, multiple myeloma is driven to spread by only a subset of the myeloma cells within a patient's body, researchers at Dana-Farber Cancer Institute have found in a study presented at the annual meeting of the American Society of Hematology (ASH). The study suggests that attacking those subsets with targeted drugs may degrade the disease's ability to spread throughout the bone marrow of affected patients, the authors say. The discovery was made by developing a mouse model of the disease that enabled researchers ...

Oral inhibitor shows clinical activity in poor-prognosis AML

2014-12-08
An oral targeted drug has shown encouraging activity and tolerable side effects in patients with treatment-resistant or relapsed acute myelogenous leukemia (AML) - a poor-prognosis group with few options - report investigators from Dana-Farber Cancer Institute and M.D. Anderson Cancer Center.   Of 32 patients treated with the oral inhibitor ABT-199, five had eradication of their leukemia and several more had stable disease, according to Anthony Letai, MD, PhD, of Dana-Farber, senior author of the report.     The phase 2 multicenter trial was the first ...

Combination therapy shown as effective for higher-risk MDS/AML patients

Combination therapy shown as effective for higher-risk MDS/AML patients
2014-12-08
A phase two study that investigated the potential of the drugs azacitidine (AZA) and lenalidomide (LEN), demonstrated that the two therapies in combination may be an effective frontline treatment regimen for patients with higher-risk forms of myelodysplastic syndrome and acute myeloid leukemia. Myelodysplastic syndrome (MDS) is a type of cancer in which the bone marrow does not make enough healthy blood cells, resulting in abnormal (blast) cells in the blood and/or bone marrow. Higher-risk patients experience an unusually large percentage of blasts in their blood. Patients ...

New study identifies first gene associated with familial glioma

2014-12-07
HOUSTON - (Dec. 7, 2014) - An international consortium of researchers led by Baylor College of Medicine has identified for the first time a gene associated with familial glioma (brain tumors that appear in two or more members of the same family) providing new support that certain people may be genetically predisposed to the disease. "It is widely thought amongst the clinical community that there is no association between family history and development of glioma. Because we know very little about the contributing genetic factors, when cases occur in two or more family ...

Study shows improved survival in aggressive acute myeloid leukemia

Study shows improved survival in aggressive acute myeloid leukemia
2014-12-07
Patients who relapse in their battle with acute myeloid leukemia (AML) may benefit from a phase three study of therapies that combine an existing agent, cytarabine, with a newer compound, vosaroxin. The study, led by Farhad Ravandi, M.D, professor of medicine, department of leukemia at The University of Texas MD Anderson Cancer Center, demonstrated increased survival rates, particularly in AML patients over age 60. Ravandi's study results were presented today at the 56th Annual Meeting of the American Society of Hematology (ASH) annual conference in San Francisco and ...

Young adults with ALL benefit from therapies developed for children

2014-12-07
Results from a large, prospective clinical trial add to mounting evidence that adolescent and young adult patients--aged 16 to 39 with acute lymphoblastic leukemia (ALL)--tend to fare better when treated with high-intensity pediatric protocols than previous patients who were treated with standard adult regimens. The intergroup trial, presented at the 56th annual meeting of the American Society of Hematology, enrolled 296 adolescent and young adult patients with ALL. All participants were treated by adult hematologists-oncologists on a pediatric protocol, including four ...

Stem cell transplant without radiation or chemotherapy pre-treatment shows promise

Stem cell transplant without radiation or chemotherapy pre-treatment shows promise
2014-12-07
SAN FRANCISCO (DECEMBER 7, 2014) - Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center report promising outcomes from a clinical trial with patients with a rare form of bone marrow failure who received a hematopoietic stem cell transplant (HSCT) after pre-treatment with immunosuppressive drugs only. This is the first trial reporting successful transplant in dyskeratosis congenita (DC) patients without the use of any radiation or conventional cytotoxic chemotherapy beforehand. The trial's data were presented by study authors Leslie Lehmann, MD, ...

LAST 30 PRESS RELEASES:

New tectonic geodynamics textbook bridges scientific disciplines

Tiny and powerful – metamaterial lenses for your phones and drones

Study used AI models to improve prediction of chronic kidney disease progression to end stage renal disease

Peanut shell biochar composite shows promise for removing antibiotic-resistant bacteria from aquaculture wastewater

Compact genetic light switches transform disease control

Sunglasses for plants, and sustainable agriculture

Nearly half of those with diabetes unaware they have the disease

Emergency department visits by uninsured children in Texas soar 45% after COVID-era federal funding ends

Bright children from poorer backgrounds twice as likely to receive hospital mental health treatment than affluent high-achievers

‘Artificial cartilage’ could improve arthritis treatment

Breathing device could have profound impact on survival for people with sleep apnoea and type 2 diabetes

Artificial intelligence assessment indicates stress levels in farmed Amazonian fish

Keith Cole receives grant to conduct integrated research on mobility, cognition and aging

Internationally recognized malaria researcher Stefan Kappe, Ph.D., appointed new director of the UM School of Medicine's Center for Vaccine Development and Global Health

Lung cancer genetics study launches open-source data platform to research community

Pre-conception radiation exposure from CT scans increases risk for miscarriage and birth defects

Boston University appoints Kenneth Lutchen to top research job

For video-on-demand platforms, release strategy matters: streaming episodes gradually boosts consumers’ searches, subscription rates

Sleep strengthens muscle and bone by boosting growth hormone levels. Here's how

Only 1 in 7 online health images show proper technique to accurately measure blood pressure

Children receiving biofeedback speech therapy improved faster than with traditional methods

Scientists discover why the flu is more deadly for older people

The salmon superfood you’ve never heard of

How does chemotherapy disrupt circadian rhythms?

A new bystander effect? Aggression can be contagious when observing it in peers.

Do you see what I see? People share brain responses for colors.

Blood test could streamline early Alzheimer's detection

New and simple detection method for nanoplastics.

Young children are not the main drivers of language change

Tarlatamab with anti-PD-L1 as first-line maintenance after chemo-immunotherapy for ES-SCLC demonstrates acceptable safety profile and unprecedented overall survival

[Press-News.org] Scientists reveal parchment's hidden stories
The new technique of analyzing DNA found in ancient parchments can shine a focused light on the development of agriculture across the centuries